An estimated 350 million people worldwide struggle with rare diseases, but only about 5% of those diseases have therapies available for their treatment. The development of these treatments –sometimes called “orphan drugs” –face special challenges. Due to the infrequency of patients presenting with these conditions, there is often a lack of understanding and experience within the medical community about managing and tre...
An estimated 350 million people worldwide struggle with rare diseases, but only about 5% of those diseases have therapies available for their treatment. The development of these treatments –sometimes called “orphan drugs” –face special challenges. Due to the infrequency of patients presenting with these conditions, there is often a lack of understanding and experience within the medical community about managing and treating them. Additionally, drug development costs may lead to funding challenges in the efforts to bring effective therapies to these small patient populations.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.